retatrutide bowel movement Retatrutide: What It Is & How This New Drug Works Retatrutide and Bowel Habits: Digestive
Description
Diarrhea (experienced by about 30% of users) often occurs in the early phase of treatment as digestion accelerates
That is where the clinical nuance lives, and it is a conversation worth having with your physician
As it will act on the GLP-1 receptor, it is likely that it may cause nausea, dizziness, or diarrhoea, but these gastrointestinal (GI) side effects usually go away as your body gets used to the treatment
11,13,17 Dipeptidyl Peptidase-4 Inhibitors Dipeptidyl peptidase-4 (DPP-4) inhibitors currently available in the U.S
Obese visceral fat tissue inflammation: from protective to detrimental
